The state of Florida has obtained thousands of monoclonal antibody treatments to treat COVID-19 from a UK-based company after the Biden administration’s abrupt rationing of federally acquired doses.
Florida went to GlaxoSmithKline, which produces monoclonals that haven’t yet been bought up by the federal government. They reached an agreement on about 3,000 doses, Gov. Ron DeSantis announced on Sept. 23.
“That’s showing that we’re going to leave no stone unturned. And, if there’s somebody that needs a monoclonal antibody treatment, we’re going to work hard to get it to them,” the Republican told a press conference in Tampa.
The Biden administration seized control of monoclonals this month, in response to what some officials have described as a national shortage. The federal government has bought millions of doses from Eli Lilly and Regeneron. The only other monoclonal authorized for use in the United States is produced by GlaxoSmithKline, or GSK. Read the rest at theepochtimes.com.
